Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 8;16(7):1059-1070.
doi: 10.1093/ckj/sfad025. eCollection 2023 Jul.

Immune abnormalities in IgA nephropathy

Affiliations
Review

Immune abnormalities in IgA nephropathy

Micaela Gentile et al. Clin Kidney J. .

Abstract

Immunoglobulin A (IgA) nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and it is characterized by mesangial IgA deposition. Asymptomatic hematuria with various degrees of proteinuria is the most common clinical presentation and up to 20%-40% of patients develop end-stage kidney disease within 20 years after disease onset. The pathogenesis of IgAN involves four sequential processes known as the "four-hit hypothesis" which starts with the production of a galactose-deficient IgA1 (gd-IgA1), followed by the formation of anti-gd-IgA1 IgG or IgA1 autoantibodies and immune complexes that ultimately deposit in the glomerular mesangium, leading to inflammation and injury. Although several key questions about the production of gd-IgA1 and the formation of anti-gd-IgA1 antibodies remain unanswered, a growing body of evidence is shedding light on the innate and adaptive immune mechanisms involved in this complex pathogenic process. Herein, we will focus on these mechanisms that, along with genetic and environmental factors, are thought to play a key role in disease pathogenesis.

Keywords: IgA nephropathy; adaptive immunity; galactose-deficient IgA1; innate immunity.

PubMed Disclaimer

Conflict of interest statement

Paolo Cravedi is an advisor for Chinook Therapeutics and Calliditas Therapeutics. The other authors have no conflict of interest to declare.

Figures

Graphical Abstract
Graphical Abstract
Figure 1:
Figure 1:
Representation of four hit hypothesis involved in the pathogenesis of IgA nephropathy.
Figure 2:
Figure 2:
IgA forms and subclasses (A and B, modified from ‘Perše M, Večerić-Haler Ž. The role of IgA in the pathogenesis of IgA nephropathy. Int J Mol Sci 2019;20:6199’). Schematic representation of the nine serine and threonine residues in the hinge region that serve as potential O-glycosylations (up to six are O-glycosylated). Six different type of O-glycans can be found in the IgA1 HR. The residues highlighted in yellow are the frequent sites with galactose-deficient O-glycan (C).

References

    1. Pattrapornpisut P, Avila-Casado C, Reich HN.. IgA nephropathy: core curriculum 2021. Am J Kidney Dis 2021;78:429–41. 10.1053/j.ajkd.2021.01.024 - DOI - PubMed
    1. Berger J. IgA glomerular deposits in renal disease. Transpl Proc 1969;1:939–44. - PubMed
    1. Rajasekaran A, Julian BA, Rizk DV.. IgA nephropathy: an interesting autoimmune kidney disease: IgA nephropathy. Am J Med Sci 2021;361:176–94. 10.1016/j.amjms.2020.10.003 - DOI - PMC - PubMed
    1. Woo KT, Chan CM, Chin YMet al. . Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract 2010;116:c337–46. 10.1159/000319594 - DOI - PubMed
    1. McGrogan A, Franssen CFM, De Vries CS.. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 2011;26:414–30. 10.1093/ndt/gfq665 - DOI - PubMed